Assignors: SMITH, ALEXANDER, STRUM, JAY COPELAND, White, Hannah S., SCHNEIDER, STEPHEN Assigned to G1 THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US202063039372P external-priority Priority to US17/097,854 priority Critical patent/US10988479B1/en Application filed by G1 Therapeutics Inc filed Critical G1 Therapeutics Inc Assigned to G1 THERAPEUTICS, INC. ![]() Original Assignee G1 Therapeutics Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) White Jay Copeland Strum Jaroslaw Mazurek Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number US17/097,854 Inventor Stephen Schneider Alexander Smith Hannah S. ![]() Google Patents Morphic forms of trilaciclib and methods of manufacture thereofÄownload PDF Info Publication number US10988479B1 US10988479B1 US17/097,854 US202017097854A US10988479B1 US 10988479 B1 US10988479 B1 US 10988479B1 US 202017097854 A US202017097854 A US 202017097854A US 10988479 B1 US10988479 B1 US 10988479B1 Authority US United States Prior art keywords pattern compound patient cancer tumor Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US10988479B1 - Morphic forms of trilaciclib and methods of manufacture thereof ![]() US10988479B1 - Morphic forms of trilaciclib and methods of manufacture thereof
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |